Södertälje, Sweden

Nils Anders Nilsson


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Sodertalje, SE (2014)
  • Södertälje, SE (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nils Anders Nilsson: Innovator in Amyloid Imaging

Introduction

Nils Anders Nilsson is a prominent inventor based in Södertälje, Sweden. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of Alzheimer's disease. With a total of 3 patents to his name, Nilsson's work focuses on developing compounds that enhance the imaging of amyloid deposits in the brain.

Latest Patents

Nilsson's latest patents include innovative compounds that serve as precursors for imaging amyloid deposits. These novel derivatives are designed for use in living patients, allowing for antemortem diagnosis of Alzheimer's disease through positron emission tomography (PET). The compounds derived from these precursors are crucial for measuring the clinical efficacy of therapeutic agents aimed at treating Alzheimer's disease. Additionally, his patents disclose these precursor compounds in crystalline form, further enhancing their utility in medical applications.

Career Highlights

Nils Anders Nilsson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has positioned him at the forefront of research aimed at improving diagnostic methods for neurodegenerative diseases. His innovative approach and dedication to advancing medical imaging technologies have made a significant impact in the field.

Collaborations

Throughout his career, Nilsson has collaborated with notable colleagues, including Katinka Ruda and Per Magnus Schou. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in the field of medical imaging.

Conclusion

Nils Anders Nilsson's contributions to the field of amyloid imaging represent a significant advancement in the diagnosis of Alzheimer's disease. His innovative patents and collaborative efforts continue to pave the way for improved diagnostic techniques, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…